20978 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons Interferons [IFN]
Placental stem cell populations
#602Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
#603METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS
#604ANTI-VIRAL THERAPY
#605Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma
#606Hepatitis C virus inhibitors
#607Compositions and methods of treating and preventing lung cancer and lymphangioleiomyomatosis
#608Two-piece, internal-channel osmotic delivery system flow modulator
#609PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#610COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATTENUATED ONCOLYTIC VIRUSES
#611Compositions and methods for modulating inflammatory and/or immune responses
#612Methods for reducing the risk of an unsuccessful pregnancy in a subject having an immune system abberation
#613Anti-arenaviral compounds
#614COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS AND TUMOURAL DISEASES
#615Use of metallocene compounds for cancer treatment
#616Thiophene analogues for the treatment or prevention of flavivirus infections
#617HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF
#618Peptidomimetic protease inhibitors
#619Methods for modulating inflammatory and/or immune responses
#620Methods for modulating inflammatory and/or immune responses
#6211′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
#622Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#623Compositions and methods for reducing the risk of preeclampsia
#624Solvent/polymer solutions as suspension vehicles
#625ALBUMIN FUSION PROTEINS
#626NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#627USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS
#628Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
#629Inhibitors
#630SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
#631Process for preparing products comprising stabilised actives and compositions comprising same
#632Methods of treating lupus
#633Method of treating tuberculosis with interferons
#634Substituted quinoline compounds and methods of use
#635COMBINATION THERAPY FOR IMMUNOSTIMULATION
#636Two-piece, internal-channel osmotic delivery system flow modulator
#637HYDROGELS USED TO DELIVER MEDICAMENTS TO THE EYE FOR THE TREATMENT OF POSTERIOR SEGMENT DISEASES
#638Inhibitors of hepatitis C virus polymerase
#639TREATMENT OF HEPATITIS C VIRUS INFECTIONS
#640ORALLY ABSORBED PHARMACEUTICAL FORMULATION AND METHOD OF ADMINISTRATION
#641Use of vitelline protein B as a microencapsulating additive
#642MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY
#643Combination therapy for proliferative disorders
#644Method of treating pulmonary disease with interferons
#645Modified human interferon polypeptides and their uses
#646Albumin fusion proteins
#647Albumin Fusion Proteins
#648Bimacrocylic HCV NS3 protease inhibitors
#649IMMUNOLOGIC COMPOUNDS FOR PREVENTION, PROTECTION, PROPHYLAXIS OR TREATMENT OF IMMUNOLOGICAL DISORDERS, INFECTIONS AND CANCER
#650THERAPEUTIC CALCIUM PHOSPHATE PARTICLES AND METHODS OF MAKING AND USING SAME
#651Combinations for HCV Treatment
#652Interferon-lambda 1 polypeptides
#653Opioid and opioid-like compounds and uses thereof
#654TSLP PROMOTES IMMUNE EVASION AND PERSISTENCE OF VIRUSES
#655IL28 AND IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
#6562'-FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT
#657Compositions and methods for modulating an immune response
#658Intralymphatic Chemotherapy Drug Carriers
#659AGENT AND METHOD FOR TREATING REFRACTORY CHRONIC HEPATITIS C
#660ANALYSIS OF HCV GENOTYPES
#661COADMINISTRATION OF ALPHA-FETOPROTEIN AND AN IMMUNOMODULATORY AGENT TO TREAT MULTIPLE SCLEROSIS
#662Reversible gel-forming compositions for controlled delivery of bioactive substances
#663CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS
#664Methods of use of cyclopamine analogs
#665Benzimidazole derivatives
#666SUBSTITUTED NUCLEOTIDE ANALOGS
#667Peptidomimetic protease inhibitors
#668Thiophene analogues for the treatment or prevention of flavivirus infections
#669METHODS AND COMPOSITIONS FOR TREATMENT
#6707-nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or derivatives thereof for treating or preventing antiviral infections
#671Compositions and methods for modulating ischemic injury
#672Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin
#673Compositions and methods for treatment of taupathy
#674HCV Combination Therapies Comprising Pegylated Interferon, Ribavirin and Telaprevir
#675Hepatitis C virus inhibitors
#676COMPOSITION AND USE OF N-ALPHA-METHYLHISTAMINE DIHYDROCHLORIDE FOR THE REDUCTION OF OXYGEN RADICAL FORMATION
#677Methods of modulating bromodomains
#678Cancer therapy based on tumor associated antigens derived from cyclin D1
#679Thienopyridine derivatives for the treatment and prevention of dengue virus infections
#680Use of IL-29 for treating a dengue virus infection
#681MHC-Less cells
#682Process for preparing antiviral compounds
#683Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor
#684Non-Invasive Method for Assessing Liver Fibrosis Progression
#685MICRONEEDLE DEVICE
#686Methods, compositions and articles of manufacture for contributing to the treatment of cancers
#687Methods and compositions for contributing to the treatment of cancers
#688Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
#689Two-piece, internal-channel osmotic delivery system flow modulator
#690Hepatitis C virus inhibitors
#691Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
#692DEUTERATED COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS
#693TREATMENT OF RHEUMATOID ARTHRITIS USING PLACENTAL STEM CELLS
#694Treatment of psoriasis using placental stem cells
#695Albumin Fusion Proteins
#696METHODS FOR TREATING CANCERS USING POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
#697Tetrazolones as inhibitors of fatty acid synthase
#698Adjuvant incorporation in immunonanotherapeutics
#699Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambda
#700PROCESS FOR NEBULIZING AQUEOUS COMPOSITIONS CONTAINING HIGHLY CONCENTRATED INSULIN
#701Solvent/polymer solutions as suspension vehicles
#702ANTITUMOUR COMPOSITIONS CONTAINING TAXANE DERIVATIVES
#703INTERFERON BETA PRODUCTION PROMOTER AND A METHOD FOR PRODUCING THEREOF
#704Immunotherapy for chronic hepatitis C virus infection
#705Hepatitis C virus inhibitors
#706METHODS OF USE FOR CYCLOPAMINE ANALOGS
#707Method of Treating Asthma with Antiviral Agents
#708Therapeutic agent for hematopoietic tumors
#709ENHANCED ANTIVIRAL THERAPY METHODS AND DEVICES
#710Method for producing soluble recombinant interferon protein without denaturing
#711Combination pharmaceutical agents as inhibitors of HCV replication
#712Particle formulations for use in pharmaceutical compositions
#713Antiviral agents
#714Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus
#715Composition and dosage form comprising a particle formulation and suspending vehicle
#716ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS
#717USE OF IMMUNOSUPPRESSANT COMPOUNDS IN A NEW INDICATION
#718Therapeutic agent for hepatitis C
#719SILIBININ COMPONENT FOR THE TREATMENT OF HEPATITIS
#720IL28 AND IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
#721ORGANIC COMPOUNDS AND THEIR USES
#722USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS
#723INTERFERON-BETA AND/OR LAMBDA FOR USE IN TREATING RHINOVIRUS INFECTION IN THE ELDERLY
#724Use of Alpha-Glucosidase Inhibitors to Treat Alphavirus Infections
#725Use of truncated cysteine IL28 and IL29 Mutants to treat cancers and autoimmune disorders
#726Antiviral nucleosides
#727β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies
#728Compositions and methods for inhibiting entry of a hepatic virus
#729IFN-ALPHA/BETA-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION THROUGH A NOVEL LIGAND-RECEPTOR PAIR: IFN- LIGANDS ENGAGE A NOVEL RECEPTOR IFN-RN (CRF2-12) AND IL-10R2 (CRF2-4) FOR SIGNALING ANDINDUCTION OF BIOLOGICAL ACTIVITIES
#730METHOD FOR TARGETED AND SUSTAINED ANTIVIRAL THERAPY
#731USE OF PEGYLATED TYPE III INTERFERONS FOR THE TREATMENT OF HEPATITIS C
#732TELAPREVIR DOSING REGIMEN
#733Modified vaccinia virus ankara for the vaccination of neonates
#734Chemical compounds
#735Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease
#7365,5-fused arylene or heteroarylene hepatitis C virus inhibitors
#737COMPOUNDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES
#738COMPOSITIONS AND METHODS FOR ORAL DRUG DELIVERY
#739THERAPY FOR VITILIGO
#7402′-branched nucleosides and mutation
#741Formulations comprising aminosterols
#742Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
#743USE OF RIBAVIRIN IN BLOOD COAGULATION DISORDER
#744Combination preparation of a biological response modifier and an anticancer agent and uses thereof
#745Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#746TETRACYCLIC INDOLE DERIVATIVES AND THEIR USE FOR TREATING OR PREVENTING VIRAL INFECTIONS
#747COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#748COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#749METHODS AND KITS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE AND PREGNANCY-RELATED DISORDERS IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#750COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION IN RECIPIENTS OF ARTIFICAL INSEMINATION
#751STABILIZATION OF HYDROPHOBIC PROTEIN THERAPEUTIC AGENTS
#752LIPOPOLYSACCHARIDE ISOLATED FROM PYRULARIA TISSUE AND/OR PYRULARIA-ASSOCIATED BACTERIA AND USES THEREOF
#753Hepatitis C virus inhibitors
#754Hepatitis C virus inhibitors
#755Hepatitis C virus inhibitors
#756Hepatitis C virus inhibitors
#757ANTI-HEPATITIS C ACTIVITY OF MESO-TETRAKIS-PORPHYRIN ANALOGUES
#758Alpha-MSH therapies for treatment of autoimmune disease
#759HCV NS3-NS4A Protease Inhibition
#760Method of treating pulmonary disease with interferons
#761Pharmaceutical composition comprising a cytokine
#762Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment
#763METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE
#764METHODS RELATED TO IMMUNOSTIMULATORY NUCLEIC ACID-INDUCED INTERFERON
#765Macrocyclic compounds as hepatitis C virus inhibitors
#766TREATMENT OF DISEASES CAUSED BY VIRAL INFECTION
#767Preparation for body surface application and preparation for body surface application-holding sheet
#768USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE
#769Stabilizing alkylglycoside compositions and methods thereof
#770Antiviral nucleosides
#771Cyclosporin analogues
#772METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS
#773Transluminal delivery of oncoltyic viruses for cancer therapy
#774Protein-carrier conjugates
#775Hepatitis C virus inhibitors
#776MODIFIED 2' AND 3' NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#777VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#778Lipidized interferon and methods of treating viral hepatitis
#779USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS
#780Placental stem cell populations
#781Methods and compositions for oral administration of protein and peptide therapeutic agents
#782SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#783METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#784Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
#785Methods of use of cyclopamine analogs
#786Use of PS20/WFDC1 and Interferons to Diagnose, Monitor and Treat Viral Diseases
#787METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF INSULIN
#788Pharmaceutical Composition for Treating Hepatitis C Virus Infection Comprising HMG-COA Reductase Inhibitor and Bile Acid
#789Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
#790Compositions and Methods for Treating Burns
#791Linked dibenzimidazole antivirals
#792Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs
#793Modified human interferon-beta polypeptides
#794HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#795INTERLEUKIN-18 BINDING PROTEINS, THEIR PREPARATION AND USE FOR THE TREATMENT OF SEPSIS
#796Methods of treating multiple sclerosis with stable liquid interferon-beta formulations
#797PEG-interferon-beta formulations
#798Method of using interferon-like potein ZCYTO20 (IL-28A) or ZCYTO22(IL-28B) to treat hepatitis B
#799Ethanol Enhances the Complete Replication of Hepatitis C Virus: the Role of Acetaldehyde
#800Linked diimidazole derivatives
#801Linked diimidazole antivirals
#802Hepatitis C Virus inhibitors
#803Hepatitis C virus inhibitors
#804MIA-2 PROTEIN
#805Controlled release pharmaceutical formulations of nitazoxanide
#806Stabilizing alkylglycoside compositions and methods thereof
#807Method for inhibiting or reducing dry eye disease by IL-1Ra
#808Cladribine regimen for treating multiple sclerosis
#809Treating Hepatitis C Virus Infection
#810Biphasic lipid-vesicle compositions
#811Cyclosporin analogues for preventing or treating hepatitis C infection
#812Dose forms comprising VX-950 and their dosage regimen
#813Albumin Fusion Proteins
#814TRANSGENIC ONCOLYTIC VIRUSES AND USES THEREOF
#815Culturing circular ssDNA viruses for the production of vaccines
#816Use of α-glucosidase inhibitors to treat alphavirus infections
#817Modulators of toll-like receptors
#818QUINAZOLINE INHIBITORS OF EGFR TYROSINE KINASE
#819Peptidomimetic protease inhibitors
#820ANTIVIRAL ACYLSULFONAMIDE DERIVATIVES
#821Antiviral nucleosides
#822Adjuvant incorporation in immunonanotherapeutics
#823SUPRA MOLECULAR CONSTRUCT FOR DELIVERY OF INTERFERON TO A MAMMAL
#824Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
#825Derivatisation of biological molecules
#826Composition and dosage form comprising a particle formulation and suspending vehicle
#827HYDRAZIDO-PEPTIDES AS INHIBITORS OF HCV NS3-PROTEASE
#828Method of treating tuberculosis with interferons
#829Highly concentrated drug particles, formulations, suspensions and uses thereof
#830Treatment of Hepatitis C Infection With Metalloporphyrins
#831Enhancement of B cell proliferation by IL-15
#832Method for reducing the risk of spontaneous abortion in a human female subject
#833Pharmaceutical compositions containing plasma protein
#834Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof
#835METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
#8362-oxo-1,2-dihydro-quinoline modulators of immune function
#837Modified vaccinia virus ankara for the vaccination of neonates
#838Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
#839Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alpha-virus-induced encephalitides
#840Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor Antibodies
#841STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS
#842INTERFERON TYPE I SUPPORTING COMPOUNDS
#843COADMINISTRATION OF ALPHA-FETOPROTEIN AND AN IMMUNOMODULATORY AGENT TO TREAT MULTIPLE SCLEROSIS
#844Methods for making and compositions comprising fermentation products of cordyceps sinensis
#845MODIFIED STAT1 TRANSGENE THAT CONFERS INTERFERON HYPERRESPONSIVENESS, METHODS AND USES THEREFOR
#846Combinations for HCV Treatment
#847Culturing circular ssDNA viruses for the production of vaccines
#848STABILIZING ALKYLGLYCOSIDE COMPOSITIONS AND METHODS THEREOF
#849SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
#850Prophylactic or therapeutic agent for viral disease
#851Compounds and compositions for delivering active agents
#852Stabilizing alkylglycoside compositions and methods thereof
#853Stabilized pharmaceutical formulations that contain the interferons gammas and alpha in synergistic proportions
#854Hepatitis C virus inhibitors
#855Compositions and methods for the treatment of viral hepatitis
#856Antibody formulations and methods of making same
#857Albumin Fusion Proteins
#858Methods and compositions for treating hepatitis C virus
#859Nucleoside derivatives for treatment of infections, including Norovirus infections
#860COMPOSITIONS AND METHODS FOR TREATING DIABETES
#861METHOD FOR TREATING OR PREVENTING CONDITIONS BY ELEVATION OF THE ADENOSINE LEVEL IN AN INDIVIDUAL
#862METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS
#863Anti-virus therapy for respiratory diseases
#864COMPOSITIONS COMPRISING EPOTHILONES AND THEIR USE FOR THE TREATMENT OF CARCINOID SYNDROME
#865AUTOMATIC SYSTEM FOR DOSE CONTROL IN TREATING HEPATITIS C USING INFUSION PUMPS
#866Carbon-substituted diketopiperazine delivery systems
#867Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereof
#868COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#869Immunodynamic complexes and methods for using and preparing such complexes
#870IFN-λ polypeptides and compositions
#871Method for treating malignant melanoma
#872USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE
#873Cyclopamine analogs
#874Orally Absorbed Pharmaceutical Formulation and Method of Administration
#875Method for Treating Polyglutamine Expansion Neurodegenerative Diseases
#876Heteroaryl-containing tripeptide HCV serine protease inhibitors
#877Kit containing stem cells and cytokines for use in attenuating immune responses
#878Stabilizing alkylglycoside compositions and methods thereof
#879COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING IMMUNE DISORDERS
#880Intralymphatic chemotherapy drug carriers
#881ADMINISTRATION OF THERAPEUTIC VIRUSES
#882VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#883Methods of treating using hormone-albumin fusion proteins
#884Opioid and opioid-like compounds and uses thereof
#885Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines
#886Oximyl HCV serine protease inhibitors
#887Methods, compositions and articles of manufacture for contributing to the treatment of cancers
#888Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B)
#889Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitors
#890Apolactoferrin Compositions and Methods for Their Use in the Treatment of Viral Hepatitis C
#891Intestinal absorptive anti-tumor agent
#892THERAPY FOR NEUROLOGICAL DISEASES
#893Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
#894Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y
#895Nucleosides with anti-hepatitis B Virus activity
#896Compositions for HCV treatment
#897TETRAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
#898Orally bioavailable lipid-based constructs
#899Cladribine regimen for treating multiple sclerosis
#900METHOD FOR DOWNREGULATING AN IMMUNE REACTION